Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, et al. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial. Lancet 2023 Mar 31:S0140-6736(23)00569-X. doi: 10.1016/S0140-6736(23)00569.
PMID: 37015244